2 weeks Ago By Defense World Staff
Investment analysts at StockNews.com initiated coverage on shares of Aeterna Zentaris ( NASDAQ:AEZS – Get Free Report ) (TSE:AEZ) in a report released on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Performance Shares of NASDAQ AEZS opened at $3.80 on Friday. The stock’s 50-day simple moving average is $4.
94 and its 200-day simple moving average is $6.55. The firm has a market capitalization of $6.
81 million, a PE ratio of -0.26 and a beta of 1.55.
Aeterna Zentaris has a fifty-two week low of $3.96 and a fifty-two week high of $12.00.
Aeterna Zentaris Company Profile ( Get Free Report ) Further Reading Five stocks we like better than Aeterna Zentaris How to Invest in the FAANG Stocks CarMax’s Impressive Rally: What Investors Should Watch Next The Risks of Owning Bonds MarketBeat Week in Review – 9/23 – 9/27 Trading Halts Explained Wake Up to This Biotech Stock That Still Has Big Potential Upside Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter ..
